Roberto Gasparini
Overview
Explore the profile of Roberto Gasparini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bechini A, Bonanni P, Moscadelli A, Lauri S, Tiscione E, Levi M, et al.
Epidemiol Prev
. 2019 May;
43(1):71-75.
PMID: 31111716
ESCULAPIO Project, funded by the Centre for Disease Prevention and Control (CCM) of the Italian Ministry of Health, for the program 2013, aims at increasing awareness on vaccine preventable infectious...
2.
de Waure C, Boccalini S, Bonanni P, Amicizia D, Poscia A, Bechini A, et al.
Eur J Public Health
. 2019 Apr;
29(5):900-905.
PMID: 30929026
Background: The elderly, defined here as subjects aged ≥ 65 years, are among at-risk subjects for whom annual influenza vaccination is recommended. For the 2018/19 season, three vaccine types are...
3.
Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, et al.
Vaccine
. 2018 Sep;
36(45):6894.
PMID: 30244871
No abstract available.
4.
Panatto D, Signori A, Lai P, Gasparini R, Amicizia D
Influenza Other Respir Viruses
. 2018 Mar;
12(4):533-543.
PMID: 29498477
Influenza has many age-dependent characteristics. A previous systematic review of randomized controlled trials showed that the detection rate of influenza B was higher in children than in non-elderly adults. However,...
5.
Di Nardo F, Boccalini S, Calabro G, Marcellusi A, Ruggeri M, Bonanni P, et al.
Ig Sanita Pubbl
. 2018 Feb;
73(5):453-471.
PMID: 29433132
Introduction: Decision-making in healthcare should rely on evidence-based approaches able to make possible a transparent and robust assessment of all the aspects related to health technologies. One of the assessment...
6.
Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, et al.
Vaccine
. 2017 Dec;
36(3):381-387.
PMID: 29224964
Background: This phase III B follow-up of an initial multicenter study (NCT00226499) will evaluate the ten-year efficacy of two doses of the combined measles-mumps-rubella-varicella vaccine (MMRV) and one dose of...
7.
Panatto D, Amicizia D, Arata L, Lai P, Gasparini R
Hum Vaccin Immunother
. 2017 Nov;
14(4):969-977.
PMID: 29172967
Squalene-based adjuvants have been included in influenza vaccines since 1997. Despite several advantages of adjuvanted seasonal and pandemic influenza vaccines, laypeople's perception of such formulations may be hesitant or even...
8.
Amicizia D, Domnich A, Arata L, Zoli D, Zotti C, Cacello E, et al.
Hum Vaccin Immunother
. 2017 Feb;
13(2):376-378.
PMID: 28215122
Post-herpetic neuralgia is the most frequent complication of herpes zoster and affects up to 30% of patients. Increased age is a well-recognized risk factor, while the role of gender is...
9.
Bechini A, Bonanni P, Lauri S, Tiscione E, Levi M, Prato R, et al.
Hum Vaccin Immunother
. 2017 Feb;
13(2):369-375.
PMID: 28215120
The ESCULAPIO Project aims at increasing awareness on vaccine preventable infectious diseases (VPID) and vaccinations in different target populations and to spread the culture of prevention. Information/training interventions on VPID...
10.
Domnich A, Arata L, Amicizia D, Puig-Barbera J, Gasparini R, Panatto D
Vaccine
. 2016 Dec;
35(4):513-520.
PMID: 28024956
Background: In the elderly, traditional influenza inactivated vaccines are often only modestly immunogenic, owing to immunosenescence. Given that adjuvantation is a means of enhancing the immune response, the trivalent inactivated...